Leukeran Tablets 2mg

Country: Malaysia

Bahasa: Inggeris

Sumber: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

Beli sekarang

Risalah maklumat Risalah maklumat (PIL)
10-10-2019
Ciri produk Ciri produk (SPC)
21-08-2019

Bahan aktif:

CHLORAMBUCIL

Boleh didapati daripada:

Aspen Medical Products Malaysia Sdn Bhd

INN (Nama Antarabangsa):

CHLORAMBUCIL

Unit dalam pakej:

25Tablet Tablets

Dikeluarkan oleh:

Excella GmbH & Co.KG

Risalah maklumat

                                _CONSUMER MEDICATION INFORMATION LEAFLET (RIMUP) _
1
LEUKERAN TABLETS
Chlorambucil (2mg)
WHAT IS IN THE LEAFLET
1.
What
LEUKERAN
Tablet
is used for
2.
How
LEUKERAN
Tablet
works
3.
Before
you
use
LEUKERAN Tablet
4.
How
to
use
LEUKERAN
Tablet
5.
While you are using it
6.
Side effects
7.
Storage
and
Disposal
of
LEUKERAN Tablet
8.
Product Description
9.
Manufacturer
and
Product
Registration Holder
10.
Date of Revision
11.
Serial Number
WHAT LEUKERAN TABLET IS
USED FOR
LEUKERAN Tablet is used to
treat some types of cancer and
certain blood disorders.
Chlorambucil is used for:
•
Hodgkin's disease and Non
Hodgkin’s
Lymphoma.
Together,
these
form
a
group
of
diseases
called
lymphomas.
They
are
cancers formed from cells
of the lymphatic system.
•
Chronic
lymphocytic
leukaemia. A type of white
blood cell cancer where the
bone
marrow
produces
a
large number of abnormal
white cells.
•
Waldenstrom's
macroglobulinaemia A rare
lymphoma associated with
an uncontrolled increase of
B-cells,
a
type
of
white
blood cell, resulting in the
release
of
an
abnormal
protein into the blood.
HOW
LEUKERAN
TABLET
WORKS
LEUKERAN Tablet contains a
medicine called Chlorambucil.
This
belongs
to
a
group
of
medicines
called
cytotoxics
(also known as chemotherapy).
It
works
by
reducing
the
number
of
abnormal
cells
in
the body.
Ask your doctor if you have
any questions about why this
medicine has been prescribed
for you. Your doctor may have
prescribed it for another reason.
BEFORE YOU USE LEUKERAN
TABLET
-
_When you must not take it _
Do not take this
medicine
if
you have an allergy to:
•
Chlorambucil,
the
active
ingredient
•
any of the other ingredients
(refer
to
section
Product
Description)
Do
not
take
LEUKERAN
Tablet if you are planning to
become
pregnant
or
father
a
child
unless
you
and
your
doctor have discussed the risks
and benefits involved.
LEUKERAN Tablet may harm
eggs
and
sperm.
Reliable
contraceptive methods must be
taken
to
avoid
pregnancy
whilst you or your partner is
taking this medicine.
Do
not
take
LEUKERAN
Tablet if you a
                                
                                Baca dokumen lengkap
                                
                            

Ciri produk

                                1
Leukeran
Chlorambucil
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 2 mg of the active ingredient chlorambucil.
PHARMACEUTICAL FORM
Brown, film	-coated, round, biconvex tablets engraved ‘GX EG 3’ on one side and ‘L’ on the
other.
CLINICAL PARTICULARS
INDICATIONS
LEUKERAN is indicated in the treatment of:	-
	Hodgkin's disease;
	certain forms of non	-Hodgkin's lymphoma;
	chronic lymphocytic leukaemia;
	Waldenstrom's macroglobulinaemia.
DOSAGE AND ADMINISTRATION
THE RELEVANT LITERATURE SH	OULD BE CONSULTED FOR FULL DETAILS OF THE
TREATMENT SCHEDULES USED.
LEUKERAN IS AN ACTIVE CYTOTOXIC AGENT FOR USE ONLY UNDER THE DIRECTION
OF PHYSICIANS EXPERIENCED IN THE ADMINISTRATION OF SUCH AGENTS.
LEUKERAN is administered orally and should be taken daily on an empty stomach (at least
one hour before meals or three hours after meals).
ADULTS
Hodgkin's disease
Used as a single agent in the palliative treatment of advanced disease a typical dos	age is 0.2
mg/kg/day for 4 to 8	weeks.
LEUKERAN is usually included in combination therapy and a number of regimes have been
used.
LEUKERAN has been used as an alternative to nitrogen mustard with a reduction in t	oxicity
but similar therapeutic	results.
                                
                                Baca dokumen lengkap
                                
                            

Dokumen dalam bahasa lain

Risalah maklumat Risalah maklumat Bahasa Melayu 10-10-2019

Cari amaran yang berkaitan dengan produk ini